Results 241 to 250 of about 45,554 (278)

The Recruitment and Retention of Individuals With Intellectual Disability in Randomized Controlled Trials: A Scoping Review

British Journal of Learning Disabilities, EarlyView.
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody, Louise Murphy, Ruth Ryan, Rosemary Lyons, Wenyi Tang, Lorna Bourke   +5 more
wiley   +1 more source

Examination of Factors Influencing Behavioural Intention of Communication Partners of People With Severe/Profound Intellectual Disabilities to Use Augmentative and Alternative Communication: Research Article

British Journal of Learning Disabilities, EarlyView.
ABSTRACT Background Communication partners have a fundamental role supporting the use of Augmentative and Alternative Communication (AAC) with people with severe/profound intellectual disabilities. Multiple, complex factors influence communication partners' preparedness to use it.
Edina Hanley, Anne‐Marie Martin, Caroline Dalton, Shelly Chakraborty, Elaine Lehane   +4 more
wiley   +1 more source

The Feasibility of a Chair Yoga Intervention to Improve Mental Health and Wellbeing for Adults With Learning Disabilities: A Pilot Study

British Journal of Learning Disabilities, EarlyView.
ABSTRACT Background Yoga has been shown to have physical benefits for people with learning disabilities. It is unclear whether the mental health and wellbeing benefits of yoga found in other populations are apparent in people with learning disabilities. This study was a pilot. Method The study comprised three stages.
Dale Metcalfe, Alice Gibson‐Fisher, Toni J. Southern, Chris Jackson   +3 more
wiley   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, EarlyView.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

L1CAM Promotes the Infiltrative Properties of Patient‐Derived Glioblastoma Cells

Cancer Science, EarlyView.
In vivo validation of L1CAM‐mediated GBM infiltration. Orthotopic transplantation of L1CAM‐expressing GBM cells into mouse brains demonstrated that L1CAM significantly promotes tumor cell infiltration and expansion in the brain parenchyma, confirming its critical role in the aggressive progression of GBM.
Asako Katsuma, Daisuke Kanematsu, Yukako Handa, Tomoko Shofuda, Atsuyo Yamamoto, Kayo Nishitani, Zhize Xiao, Daisuke Kawauchi, Kentarou Baba, Naoyuki Inagaki, Yonehiro Kanemura   +10 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

X‐Linked intellectual disability update 2022

American Journal of Medical Genetics Part A, 2022
AbstractGenes that are involved in the transcription process, mitochondrial function, glycoprotein metabolism, and ubiquitination dominate the list of 21 new genes associated with X‐linked intellectual disability since the last update in 2017. The new genes were identified by sequencing of candidate genes (2), the entire X‐chromosome (2), the whole ...
Charles E. Schwartz, Raymond J. Louie, Annick Toutain, Cindy Skinner, Michael J. Friez, Roger E. Stevenson   +5 more
openaire   +3 more sources

The Neurobiology of X-Linked Intellectual Disability

The Neuroscientist, 2013
X-linked intellectual disability (XLID) affects 1% to 3% of the population. XLID subsumes several heterogeneous conditions, all of which are marked by cognitive impairment and reduced adaptive skills. XLID arises from mutations on the X chromosome; to date, 102 XLID genes have been identified.
Bassani Silvia, Zapata Jonathan, Gerosa Laura, Moretto Edoardo, Murru Luca, Passafaro Maria   +5 more
openaire   +3 more sources

IQSEC2 and X-linked syndromal intellectual disability

Psychiatric Genetics, 2016
Despite the recent acceleration in the discovery of genetic risk factors for intellectual disability (ID), the genetic etiology of ID is unknown in approximately half of cases and remains a major frontier of genetics in medicine and psychiatry. The distinction between syndromal and nonsyndromal forms of ID is of great clinical importance, but the ...
Aaron F, Alexander-Bloch, Christopher J, McDougle, Zhanna, Ullman, David A, Sweetser   +3 more
openaire   +2 more sources

ZDHHC9 X‐linked intellectual disability: Clinical and molecular characterization

American Journal of Medical Genetics. Part A, 2022
The ZDHHC9 gene encodes the Zinc Finger DHHC‐Type Containing 9 protein that functions as a palmitoyltransferase. Variants in this gene have been reported as the cause of Raymond‐type X‐linked intellectual disability with only 16 families described in the
Anna Karolina Silva Ramos, Erica Carine Campos Caldas-Rosa, B. M. Ferreira, B. Versiani, P. Moretti, S. F. de Oliveira, A. Pic‐Taylor, J. Mazzeu   +7 more
semanticscholar   +1 more source